Related Experiment Videos
Muramyl dipeptide induces acute joint inflammation in the mouse
Microbiology and Immunology
|January 1, 1986
Summary
Synthetic muramyl dipeptide (MDP) and its derivatives can induce acute joint inflammation in mice. Specific structural modifications, like adding a stearoyl group, enhance and prolong these inflammatory joint lesions.
Area of Science:
- Immunology
- Pharmacology
- Rheumatology
Background:
- Muramyl dipeptide (MDP) is a component of bacterial cell walls known for its immunomodulatory properties.
- MDP and its analogs are investigated for their potential as adjuvants in vaccines and their ability to induce inflammatory responses.
Purpose of the Study:
- To investigate the ability of synthetic muramyl dipeptide (MDP) and its derivatives to induce acute joint inflammation.
- To determine the structure-activity relationship of MDP analogs in causing joint lesions.
Main Methods:
- Acute joint inflammation was induced in BALB/c mice via single intravenous injections of synthetic MDP, its stereoisomers, and 6-O-acyl derivatives.
- Joint swelling and erythema were monitored over a period of 3-4 days post-injection.
Main Results:
- Four adjuvant-active MDP analogs induced acute swelling and erythema in mouse ankles and wrists.
- Inflammatory lesions peaked at 18-24 hours and subsided by days 3-4.
- Introducing a stearoyl group at the C-9 hydroxyl position enhanced and prolonged joint lesions compared to MDP alone.
Conclusions:
- Specific structural features of MDP analogs are critical for inducing acute joint inflammation.
- The stearoyl group modification significantly potentiates MDP-induced joint inflammation, suggesting a role in adjuvant activity.